Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
With questions already swirling about the real affordability impact of the government’s drug purchasing portal…
President Donald Trump bought $680,000 in stock in Eli Lilly and Co., the maker of…
Jury awards $885 million verdict in Takeda Pharmaceutical antitrust delay damages lawsuit
By healthadmin
Takeda Pharmaceutical plans to appeal after a federal jury found it liable in a landmark…
Novartis terminates plant contract with Chinese CDMO Porton, threatens $64 million legal claim
By healthadmin
Novartis’ cross-border partnerships are at odds. A Swiss pharmaceutical company has unilaterally terminated its factory…
Even as the specter of new drug prices looms over President Donald Trump’s Most Favored…
AstraZeneca also uses approved sweetener for Fasenra, granted important FDA nod in hypertension
By healthadmin
After showing impressive Phase 3 results last fall, AstraZeneca’s bet on Cincor Pharma and its…
In the past 18 months, Merck and Cologne Biotech have secured four approvals in China…
Eli Lilly is setting up a huge manufacturing facility in Houston, but it’s not the…
First, AstraZeneca’s Enhertz receives double FDA approval to treat early-stage breast cancer
By healthadmin
Enhertu’s market conquest continues apace. Daiichi Sankyo and AstraZeneca’s star antibody-drug conjugate, which already has…
The case for direct patient care is clear, but the challenge ahead is successful implementation
By healthadmin
Direct-to-patient (DTP) claims are clearly stated. Unify the prescription process and create a frictionless, branded…